Eli Lilly Buys Psychedelics Maker Atai Beckley for $2.8 Billion to Develop DMT-Like Depression Drug

24/7 Wall St.·Jul 16

This story is reported by 24/7 Wall St.. Read what other outlets are saying below, then open the original report for full details.